5.11
0.44 (9.42%)
| Penutupan Terdahulu | 4.67 |
| Buka | 4.65 |
| Jumlah Dagangan | 525,171 |
| Purata Dagangan (3B) | 247,516 |
| Modal Pasaran | 210,519,584 |
| Harga / Jualan (P/S) | 97.52 |
| Harga / Buku (P/B) | 165.91 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Nov 2025 |
| Margin Operasi (TTM) | -3,917.27% |
| EPS Cair (TTM) | -3.47 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -27.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.68% |
| Nisbah Semasa (MRQ) | 3.67 |
| Aliran Tunai Operasi (OCF TTM) | -67.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -48.03 M |
| Pulangan Atas Aset (ROA TTM) | -135.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -263.65% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Anteris Technologies Global Cor | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 1.0 |
| Purata | -0.50 |
|
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.21% |
| % Dimiliki oleh Institusi | 64.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Rhenman & Partners Asset Management Ab | 30 Sep 2025 | 1,250,763 |
| Julat 52 Minggu | ||
| Median | 16.00 (213.11%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wells Fargo | 11 Mar 2026 | 16.00 (213.11%) | Beli | 6.20 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 22 Jan 2026 | Pengumuman | Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises |
| 22 Jan 2026 | Pengumuman | Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock |
| 20 Jan 2026 | Pengumuman | Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering |
| 20 Jan 2026 | Pengumuman | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |